Research
Hormonal
Tirzepatide treatment significantly decreased serum glucose levels after fasting and improved glucose tolerance compared with semaglutide treatment.
Tirzepatide may offer better glycemic control than semaglutide in obese individuals.
StrongSupportsmedium confidence
Further, tirzepatide treatment improved glucose tolerance compared with semaglutide treatment.
Why this rating
Supported by comparative analysis of treatment effects.
Source
Dual GIPR and GLP‐1R agonist tirzepatide inhibits aeroallergen‐induced allergic airway inflammation in mouse model of obese asthma
Shinji Toki et al. · Clinical & Experimental Allergy · 2022
otherCited 16×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →